EUVIMEDEUVIMED entdecken
Crossref

Immune landscape of the kidney allograft in response to rejection

Harsimar Kaur Ahuja, Shafquat Azim iD, Daniel Maluf, Valeria R Mas iD

Clinical Science · 2023

DOI: 10.1042/cs20230493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2023. Verfasst von Harsimar Kaur Ahuja und 3 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Sciences Division, Department of Surgery, School of Medicine, University of Maryland, Baltimore, MD 21201, U.S.A. Hauptthemen laut MEDLINE: Graft Rejection, Kidney Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 129 Literaturangaben. Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID), Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preventing kidney graft dysfunction and rejection is a critical step in addressing the nationwide organ shortage and improving patient outcomes. While kidney transplants (KT) are performed more frequently, the overall number of patients on the waitlist consistently exceeds organ availability. Despite improved short-term outcomes in KT, comparable progress in long-term allograft survival has not been achieved. Major cause of graft loss at 5 years post-KT is chronic allograft dysfunction (CAD) characterized by interstitial fibrosis and tubular atrophy (IFTA). Accordingly, proactive prevention of CAD requires a comprehensive understanding of the immune mechanisms associated with either further dysfunction or impaired repair. Allograft rejection is primed by innate immune cells and carried out by adaptive immune cells. The rejection process is primarily facilitated by antibody-mediated rejection (ABMR) and T cell-mediated rejection (TCMR). It is essential to better elucidate the actions of individual immune cell subclasses (e.g. B memory, Tregs, Macrophage type 1 and 2) throughout the rejection process, rather than limiting our understanding to broad classes of immune cells. Embracing multi-omic approaches may be the solution in acknowledging these intricacies and decoding these enigmatic pathways. A transition alongside advancing technology will better allow organ biology to find its place in this era of precision and personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionKidney TransplantationHumansKidneyTransplantation, HomologousAllografts

Stichwörter der Autor:innen

Acute rejectionAlloimmune responseChronic allograft dysfunctionImmune cellsKidney transplantationSingle cell approaches

Autor:innen und Institutionen

  • Surgical Sciences Division, Department of Surgery, School of Medicine, University of Maryland, Baltimore, MD 21201, U.S.A.
  • Program of Transplantation, School of Medicine, 29S Greene St, University of Maryland, Baltimore, MD 21201, U.S.A.

ORCID-Profile: Shafquat Azim, Valeria R Mas

Förderung

  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
  • Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Zitieren

APA

Ahuja, H. K., Azim, S., Maluf, D., & Mas, V. R. (2023). Immune landscape of the kidney allograft in response to rejection. Clinical Science. https://doi.org/10.1042/cs20230493

Vancouver

Ahuja HK, Azim S, Maluf D, Mas VR. Immune landscape of the kidney allograft in response to rejection. Clinical Science. 2023. doi:10.1042/cs20230493

BibTeX
@article{Ahuja2023,
  author = {Ahuja, Harsimar Kaur and Azim, Shafquat and Maluf, Daniel and Mas, Valeria R},
  title = {Immune landscape of the kidney allograft in response to rejection},
  journal = {Clinical Science},
  year = {2023},
  doi = {10.1042/cs20230493}
}
Kostenlos starten →